These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3069238

  • 1. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite.
    Ewan PW, Alexander MM, Snape C, Ind PW, Agrell B, Dreborg S.
    Clin Allergy; 1988 Sep; 18(5):501-8. PubMed ID: 3069238
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial.
    Varney VA, Tabbah K, Mavroleon G, Frew AJ.
    Clin Exp Allergy; 2003 Aug; 33(8):1076-82. PubMed ID: 12911781
    [Abstract] [Full Text] [Related]

  • 3. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
    Wang DH, Chen L, Cheng L, Li KN, Yuan H, Lu JH, Li H.
    Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
    [Abstract] [Full Text] [Related]

  • 4. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses.
    McHugh SM, Lavelle B, Kemeny DM, Patel S, Ewan PW.
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):521-31. PubMed ID: 1699985
    [Abstract] [Full Text] [Related]

  • 5. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M, Eifan AO, Keles S, Akkoc T, Nursoy MA, Bahceciler NN, Barlan IB.
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [Abstract] [Full Text] [Related]

  • 6. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study.
    Guez S, Vatrinet C, Fadel R, André C.
    Allergy; 2000 Apr; 55(4):369-75. PubMed ID: 10782522
    [Abstract] [Full Text] [Related]

  • 7. Effects of one-year hyposensitization in allergic rhinitis. Comparison of two house dust mite extracts.
    Pécoud A, Nicod L, Badan M, Agrell B, Dreborg S, Kolly M.
    Allergy; 1990 Jul; 45(5):386-92. PubMed ID: 2378442
    [Abstract] [Full Text] [Related]

  • 8. Hyposensitization with a tyrosine adsorbed extract of Dermatophagoides pteronyssinus in adults with perennial rhinitis. A controlled clinical trial.
    Blainey AD, Phillips MJ, Ollier S, Davies RJ.
    Allergy; 1984 Oct; 39(7):521-8. PubMed ID: 6388401
    [Abstract] [Full Text] [Related]

  • 9. Reduction of increased serum neutrophil chemotactic activity following effective hyposensitization in house dust mite allergy.
    McHugh SM, Ewan PW.
    Clin Exp Allergy; 1989 May; 19(3):327-34. PubMed ID: 2660970
    [Abstract] [Full Text] [Related]

  • 10. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite.
    Scadding GK, Brostoff J.
    Clin Allergy; 1986 Sep; 16(5):483-91. PubMed ID: 3536171
    [Abstract] [Full Text] [Related]

  • 11. Clinical effects of specific immunotherapy: a two-year double-blind, placebo-controlled study with a one year follow-up.
    Dokic D, Schnitker J, Narkus A, Cromwell O, Frank E.
    Prilozi; 2005 Dec; 26(2):113-29. PubMed ID: 16400234
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V, Batard T, Nguyen H, Fréreux M, Horiot S, Harwanegg C, Bergmann KC, de Beaumont O, Moingeon P.
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [Abstract] [Full Text] [Related]

  • 14. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
    Gallego MT, Iraola V, Himly M, Robinson DS, Badiola C, García-Robaina JC, Briza P, Carnés J.
    Int Arch Allergy Immunol; 2010 Oct; 153(1):61-9. PubMed ID: 20357486
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
    Tari MG, Mancino M, Monti G.
    Allergol Immunopathol (Madr); 1990 Oct; 18(5):277-84. PubMed ID: 2097894
    [Abstract] [Full Text] [Related]

  • 18. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A, Vega-Chicote JM, Fernández S, Miranda A, Carmona MJ, Rondón MC, Reina E, García-González JJ.
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [Abstract] [Full Text] [Related]

  • 19. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
    Saraçlar Y, Sekerel BE, Kalayci O, Adalioğlu G, Tuncer A.
    J Investig Allergol Clin Immunol; 1998 Sep; 8(2):98-104. PubMed ID: 9615303
    [Abstract] [Full Text] [Related]

  • 20. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis.
    Bozek A, Ignasiak B, Filipowska B, Jarzab J.
    Clin Exp Allergy; 2013 Feb; 43(2):242-8. PubMed ID: 23331565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.